Status:
COMPLETED
Screening for Albuminuria at the First Line for Early Identification of CKD
Lead Sponsor:
General Practitioners Research Institute
Collaborating Sponsors:
University Medical Center Groningen
Conditions:
Chronic Kidney Diseases
Albuminuria
Eligibility:
All Genders
18-80 years
Brief Summary
Early detection of kidney disease
Detailed Description
Early detection and appropriate treatment of kidney disease is important as this may prevent future cardiovascular complications and end-organ damage more effectively than intervention in more advance...
Eligibility Criteria
Inclusion
- Diabetes Mellitus (diagnosis or prescription for the disease based on the NHG guidelines)
- Adipositas (diagnosis)
- Hypertension (diagnosis or prescription for the disease based on the NHG guidelines)
- Cardiovascular disease (diagnosis, specified in protocol section 5.2.2)
- Lipid disorder (diagnosis or prescription for the disease based on the NHG guidelines)
Exclusion
- Inability to understand and sign the informed consent form
- Pregnancy
Key Trial Info
Start Date :
November 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 30 2024
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT05321095
Start Date
November 25 2021
End Date
July 30 2024
Last Update
August 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Practitioners Research Institute
Groningen, Netherlands, 9713GH